title: Spironolactone increases serum uric acid levels in patients with chronic kidney disease.
authors.affiliation: Nephrology Section, Clinical Hospital, Universidad de Chile and Critical Care Center, Clínica las Condes, Santiago, Chile.
authors.forename: S E
authors.initials: SE
authors.lastname: Cabrera
authors.affiliation: Department of Cardiology, University Hospital Birmingham, University of Birmingham, Birmingham, UK.
authors.forename: N C
authors.initials: NC
authors.lastname: Edwards
authors.affiliation: Department of Cardiology, University Hospital Birmingham, University of Birmingham, Birmingham, UK.
authors.forename: R P
authors.initials: RP
authors.lastname: Steeds
authors.affiliation: Department of Cardiology, University Hospital Birmingham, University of Birmingham, Birmingham, UK.
authors.forename: J N
authors.initials: JN
authors.lastname: Townend
authors.affiliation: Department of Nephrology, University Hospital Birmingham, University of Birmingham, Birmingham, UK.
authors.forename: C J
authors.initials: CJ
authors.lastname: Ferro
mesh_terms: D004232:Diuretics / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000188:drug therapy*; D012189:Retrospective Studies; D013148:Spironolactone / Q000627:therapeutic use*; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood*
chemical_list: D004232:Diuretics; D014527:Uric Acid; D013148:Spironolactone